Development of DNA-biochips for rational prescription of psychopharmaceuticals (Q11681)

From EU Knowledge Graph
Revision as of 15:32, 22 October 2020 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): The aim of the project is to develop a new DNA-biochip for a streamlined psychologist for patients with psychiatric illness, thereby bringing benefits not only to the patient but to reducing the costs of health insurance companies. The project will benefit from a safer and more effective psychopharmacy, leading to more successful pharmacotherapy, increasing the comfort of the patient in the form of positive therapy, and reducing the costs of t...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Development of DNA-biochips for rational prescription of psychopharmaceuticals
Project in Czech Republic financed by DG Regio

    Statements

    contained in NUTS
    Prague
    0 references
    Prague
    0 references
    country
    Czechia
    0 references
    EU contribution
    7,740,698.75 Czech koruna
    0 references
    309,627.95 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    11,073,961.0 Czech koruna
    0 references
    442,958.44 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    69.9 percent
    0 references
    expected end time
    31 October 2020
    0 references
    beneficiary name (string)
    ESSENCE LINE, s.r.o.
    0 references
    beneficiary
    ESSENCE LINE
    0 references
    coordinate location

    50°4'11.50"N, 14°22'51.56"E
    0 references

    50°4'6.46"N, 14°23'8.41"E
    0 references
    postal code
    15000
    0 references
    15000
    0 references
    summary
    Cílem projektu je vyvinout nový DNA-biochip pro racionalizovanou preskripci psychofarmak pro pacienty s psychiatrickým onemocněním a tím přinést prospěch nejen pacientovi, ale snížit náklady zdravotních pojišťoven. Přínosem projektu bude bezpečnější a efektivnější preskripce psychofarmak, což povede k úspěšnější farmakoterapii, zvýší komfort pacienta v podobě pozitivní terapie a sníží náklady na neefektivně aplikovaná psychofarmaka a negativní dopady na pacienta. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/17_107/0012433
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11681&oldid=6599395"